Targeting mitochondria in pulmonary hypertension
Pulmonary Arterial Hypertension (PAH) is a debilitating disease of the lung blood vessels that causes heart failure and early death, affecting hundreds of thousands of patients worldwide. Available therapies fail to prolong life, despite costs that may exceed $200,000/patient per year. A team of investigators at the University of Alberta (Edmonton, Canada), and the Imperial College of Medicine (London, UK), reported promising results of an early-…
A Rehab Journey to New Dreams
Rebecca André was 21 years old when she first developed blood clots. As her condition got worse, Rebecca had more difficulty breathing and moving, and had gained weight. Eventually, she was diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a rare type of pulmonary hypertension (PH) where thrombi (fibrinous clot masses) get stuck to the lung’s blood vessel walls and block the blood flow from the heart to the lungs. Thi…
World’s first simulator for pulmonary endarterectomy will bring life-saving skill to more thoracic surgeons
Thoracic surgeon Dr. Marc De Perrot, has developed the world's first pulmonary endarterectomy simulator in an effort to decrease the length of time it takes new surgeons to learn the technique, thereby broadening the pool of specialists who can offer the procedure.
Interview with Susan Bailey and Dr. George Chandy
Interview with Susan Bailey and Dr. George Chandy on the Carole Anne Meehan Show (1310 NEWS).
Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition where there is elevated blood pressure in the pulmonary arteries caused by chronic blood clots (thromboembolic), which obstruct the free flow of blood through the lungs.
Interview with James Altimas and Donna Downes
Interview with James Altimas, PH patient, and Donna Downes, on Rogers TV Ottawa.
Canadian Association Conducting Purple Challenge Campaign During PH Awareness Month
The Pulmonary Hypertension Association of Canada is conducting a Life in Purple Challenge this month as part of its efforts to mark November as Pulmonary Hypertension Awareness Month.
Pulmonary Hypertension Association of Canada Launches New Educational Campaign Targeting Medical Professionals for World Pulmonary Hypertension Day 2017
The Pulmonary Hypertension Association of Canada (PHA Canada) will mark the 6th annual World Pulmonary Hypertension Day on May 05, 2017 with the launch of Sometimes It’s PH, a new educational campaign targeting medical professionals. On May 05th, PHA Canada will release its new website featuring information on pulmonary hypertension (PH) including its signs and symptoms, risk factors, diagnosis, and treatment.
25 years later, Saskatoon woman thankful for second chance
A quarter century later, Sherry Duncan Paterson still remembers exactly what her husband Bob told her when she woke up. “When I was sick I was very blue and grey. And the first words my husband said to me were the best words I’ve ever heard, I think, in my whole life — ‘You’re so pink.’ And then I knew I would be okay.” She first felt something was wrong a few weeks after the birth of her second daughter. She was breathless just from climbi…
iPSCs Uncover Protective Pathways Against Carriers of BMPR2 Mutation
Contrary to what we learned in our high school biology classes, not all genetic diseases are easy to predict. Many of you may remember Punnett Squares, where we were able to determine the likelihood of a child having certain outcomes or diseases. While cystic fibrosis (CF) often is the pulmonary poster child of genetic disease, we’ve learned that pulmonary hypertension is far more complicated. For example, in cystic fibrosis, two parents who a…
Recent News


Get the latest on PH treatments, community events and more when you subscribe to our newsletter